{"id":"W4311719624","doi":"10.51731/cjht.2022.520","title":"Pembrolizumab in Combination With Lenvatinib (Keytruda and Lenvima)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Lenvatinib; Pembrolizumab; Medicine; Reimbursement; Internal medicine; Oncology; Sorafenib; Cancer; Immunotherapy; Hepatocellular carcinoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004396658,0.0002030793,0.0002277567,0.0005800859,0.0001748435,0.0005944466,0.0002389592,0.0003738159,0.01117529],"category_scores_gemma":[0.0005271125,0.00007974385,0.0004059256,0.0004421009,0.0001498493,0.000416571,0.0002326017,0.0004001317,0.001904012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001024387,"about_ca_system_score_gemma":0.0008819578,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005190412,"about_ca_topic_score_gemma":0.02458607,"domain_scores_codex":[0.999779,0.0000640472,0.00002521776,0.00003321873,0.00006752956,0.00003087138],"domain_scores_gemma":[0.9998761,0.00002513087,0.00004274983,0.000005251746,0.00003261308,0.0000180087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001577418,0.0001897256,0.002037003,0.003484303,0.0003762852,0.0003199923,0.00003718025,0.0002269118,0.01133779,0.00246108,0.05324103,0.9247113],"study_design_scores_gemma":[0.001182778,0.003579862,0.017361,0.002654999,0.000724161,0.002682129,0.0001018393,0.0003124249,0.01219753,0.0009016628,0.9582763,0.00002535143],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0415524,0.7914856,0.001607896,0.008526854,0.001462495,0.0003906658,0.001822082,0.0001921585,0.1529598],"genre_scores_gemma":[0.4262796,0.4374391,0.007623014,0.009621941,0.001029691,0.0003376109,0.003429137,0.00004173805,0.1141983],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01117529,"threshold_uncertainty_score":0.03738505,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02804367635266003,"score_gpt":0.2806465541397167,"score_spread":0.2526028777870566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}